CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion

Cancer Immunology, Immunotherapy

Volumn 62, Issue 2, 2013, Pages 273-283

  Dumas, Geneviève ^a   Dufresne, Mathieu ^a   Asselin, Éric ^a   Girouard, Julie ^a   Carrier, Christian ^b   Reyes Moreno, Carlos ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b Regional Hospital of Trois Rivieres   (Canada)

Author keywords

CD40 receptor; Endometrial cancer; Immunotherapy; Polarized macrophages; Tumor stroma interaction

Indexed keywords

CASPASE 3; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME MODIFICATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERLEUKIN 6 GENE; LIF GENE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR NECROSIS FACTOR ALPHA GENE; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD40; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874115283     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1333-2     Document Type: Article

References (45)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366:491-505. doi: 10.1016/S0140-6736(05)67063- 8
2. Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH (2007) Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 62: 28-34; discussion 35-26. doi: 10.1016/j.crad.2006.06. 015
3. Stout RD, Suttles J (1996) The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17:487-492
4. Schonbeck U, Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58:4-43
5. Peters AL, Stunz LL, Bishop GA (2009) CD40 and autoimmunity: the dark side of a great activator. Semin Immunol 21:293-300. doi: 10.1016/j.smim.2009. 05.012
6. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229:152-172. doi: 10.1111/j.1600-065X.2009.00782.x
7. Costello RT, Gastaut JA, Olive D (1999) What is the real role of CD40 in cancer immunotherapy? Immunol Today 20:488-493
8. Eliopoulos AG, Young LS (2004) The role of the CD40 pathway in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4:360-367
9. Vonderheide RH (2007) Prospect of targeting the CD40 pathway for cancer therapy. Clin Cancer Res 13:1083-1088. doi: 10.1158/1078-0432.CCR-06-1893
10. Bereznaya NM, Chekhun VF (2007) Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy. Exp Oncol 29:2-12
11. Dufresne M, Dumas G, Asselin E, Carrier C, Pouliot M, Reyes-Moreno C (2011) Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells. Mol Immunol 48:1556-1567. doi: 10.1016/j.molimm.2011.04.022
12. Buhtoiarov IN, Lum H, Berke G, Paulnock DM, Sondel PM, Rakhmilevich AL (2005) CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro. J Immunol 174:6013-6022
13. Rakhmilevich AL, Buhtoiarov IN, Malkovsky M, Sondel PM (2008) CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors. Cancer Immunol Immunother 57:1151-1160. doi: 10.1007/s00262-007-0447-4
14. Lum HD, Buhtoiarov IN, Schmidt BE, Berke G, Paulnock DM, Sondel PM, Rakhmilevich AL (2006) In vivo CD40 ligation can induce T-cell-independent antitumor effects that involve macrophages. J Leukoc Biol 79:1181-1192. doi: 10.1189/jlb.0405191
15. Reyes-Moreno C, Girouard J, Lapointe R, Darveau A, Mourad W (2004) CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J Biol Chem 279:7799-7806
16. Girouard J, Reyes-Moreno C, Darveau A, Akoum A, Mourad W (2005) Requirement of the extracellular cysteine at position six for CD40/CD40 dimer formation and CD40-induced IL-8 expression. Mol Immunol 42:773-780
17. Reyes-Moreno C, Sharif-Askari E, Girouard J, Leveille C, Jundi M, Akoum A, Lapointe R, Darveau A, Mourad W (2007) Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling. J Biol Chem 282:19473-19480
18. Dery MC, Van Themsche C, Provencher D, Mes-Masson AM, Asselin E (2007) Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro. Reprod Biol Endocrinol 5:38. doi: 10.1186/1477-7827-5-38
19. Rouette A, Parent S, Girouard J, Leblanc V, Asselin E (2012) Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells. Int J Cancer 130:1755-1767. doi: 10.1002/ijc.26183
20. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254-265
21. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209-212
22. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964. doi: 10.1038/nri1733
23. Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263-266
24. Chakraborty NG, Okino T, Stabach P, Padula SJ, Yamase H, Morse E, Sha'afi RI, Twardzik DR, Shultz LJ, Mukherji B (1991) Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in SCID mice. In Vivo 5:609-614
25. Craig M, Ying C, Loberg RD (2007) Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo. J Cell Biochem 103:1-8
26. Salvesen HB, Akslen LA (1999) Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 84:538-543
27. Fujimoto J, Aoki I, Khatun S, Toyoki H, Tamaya T (2002) Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers. Ann Oncol 13:430-434
28. Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H, Kohchi C, Soma G, Inoue M (2004) Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24:3335-3342
29. Conzelmann M, Wagner AH, Hildebrandt A, Rodionova E, Hess M, Zota A, Giese T, Falk CS, Ho AD, Dreger P, Hecker M, Luft T (2010) IFN-gamma activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production. Biochem Pharmacol 80:2074-2086. doi: 10.1016/j.bcp.2010.07.040
30. Shurin MR, Yurkovetsky ZR, Tourkova IL, Balkir L, Shurin GV (2002) Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer 101:61-68. doi: 10.1002/ijc.10576
31. Murugaiyan G, Agrawal R, Mishra GC, Mitra D, Saha B (2006) Functional dichotomy in CD40 reciprocally regulates effector T cell functions. J Immunol 177:6642-6649
32. Murugaiyan G, Martin S, Saha B (2007) Levels of CD40 expression on dendritic cells dictate tumour growth or regression. Clin Exp Immunol 149:194-202. doi: 10.1111/j.1365-2249.2007.03407.x
33. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361-371
34. Hodge DR, Hurt EM, Farrar WL (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41:2502-2512
35. Mylonas I, Makovitzky J, Shabani N, Richter DU, Kuhn C, Jeschke U, Briese V, Friese K (2005) Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue. Eur J Obstet Gynecol Reprod Biol 118:101-108
36. Lu Y, Wahl LM (2005) Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/ NF-kappaB pathway. J Leukoc Biol 78:259-265. doi: 10.1189/jlb.0904498
37. Malik N, Greenfield BW, Wahl AF, Kiener PA (1996) Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 156:3952-3960
38. Zhou M, Zhang Y, Ardans JA, Wahl LM (2003) Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. J Biol Chem 278:45406-45413. doi: 10.1074/jbc.M309075200
39. Phipps RP (2000) Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 97:6930-6932
40. Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E (2004) T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets 3:35-42
41. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175:342-349
42. Kelly RW, King AE, Critchley HO (2002) Inflammatory mediators and endometrial function-focus on the perivascular cell. J Reprod Immunol 57:81-93
43. King AE, Kelly RW, Critchley HO, Malmstrom A, Sennstrom M, Phipps RP (2001) Cd40 expression in uterine tissues: a key regulator of cytokine expression by fibroblasts. J Clin Endocrinol Metab 86:405-412
44. Altenburg A, Baldus SE, Smola H, Pfister H, Hess S (1999) CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma. J Immunol 162:4140-4147
45. Gallagher NJ, Eliopoulos AG, Agathangelo A, Oates J, Crocker J, Young LS (2002) CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion. Mol Pathol 55:110-120